Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Intellectual Bias Policy Takes Wolfe Off Contraceptives Safety Review

Dec 06 2011

• By Cathy Dombrowski

Related Content

Non-Contraceptive Use Could Confound Safety Evaluation Of Drospirenone-Containing Products

Dec 06 2011

Prasugrel Intellectual Bias: FDA Makes Changes, Congress Demands Answers

Mar 09 2009

FDA Advisory Committees Would Get Patient Influence Under Hagan Bill

Nov 14 2011

Public Citizen Demands Removal of J&amp;J’s Ortho Evra Patch From Marketplace

May 08 2008

Prasugrel Advisory Committee Highlights FDA’s Continued Credibility Gap

Feb 09 2009

Additional Topics

Risk Management Advisory Committees

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window